Portfolio company
InkVivo
Switzerland · £1.1m raised
Raised
£1.1m
Latest stage
Pre-seed
Rounds recorded
1
Backed by
2 investors
Sectors
About
The company develops polymer-based drug delivery systems for pharmaceutical and nutraceutical industries to enhance therapeutic adherence and efficacy.
SourceFunding history · 1
Similar companies
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.
SEncIL
SEncIL develops encapsulation technology that transforms liquid drugs into polymer-encapsulated powders to improve oral drug delivery for pharmaceutical companies.
Exolvo Biosciences
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
BioSapien
This company develops 3D-printed biodegradable mesh for localized and sustained delivery of chemotherapy drugs to cancer patients.
NaDeNo
This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.
TUUS Solutions
This company develops a plant-based hydrogel platform for the controlled release of nutrients and drugs, primarily serving endurance athletes and nutrition companies.
VIVOLTA
This company develops and manufactures electrospun medical products, such as implants and drug delivery solutions, for medical device and pharmaceutical companies.
